0001140361-18-012878.txt : 20180309 0001140361-18-012878.hdr.sgml : 20180309 20180309172425 ACCESSION NUMBER: 0001140361-18-012878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180307 FILED AS OF DATE: 20180309 DATE AS OF CHANGE: 20180309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Havey Adam CENTRAL INDEX KEY: 0001514588 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 18681150 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20853 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2018-03-07 0 0001367644 Emergent BioSolutions Inc. EBS 0001514588 Havey Adam 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Business Operations Common Stock 2018-03-07 4 M 0 6573 22.03 A 39573 D Common Stock 2018-03-07 4 F 0 2843 50.43 D 36730 D Stock Option (Right to Buy) 22.03 2018-03-07 4 M 0 6573 0.00 D 2014-03-14 2018-03-14 Common Stock 6573 0 D Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock option exercise. Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. The option vested in three equal installments in March 2012, March 2013 and March 2014. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. /s/ Eric Burt, Attorney-in-fact 2018-03-09